悦心健康
(002162)
| 流通市值：40.23亿 | | | 总市值：40.28亿 |
| 流通股本：9.18亿 | | | 总股本：9.20亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 210,618,689.84 | 1,061,871,436.31 | 771,308,298.16 | 487,990,289.05 |
| 营业收入 | 210,618,689.84 | 1,061,871,436.31 | 771,308,298.16 | 487,990,289.05 |
| 利息收入 | 0 | - | - | 0 |
| 已赚保费 | 0 | - | - | 0 |
| 手续费及佣金收入 | 0 | - | - | 0 |
| 二、营业总成本 | 210,377,083.24 | 1,054,181,699.28 | 772,782,653.64 | 489,644,237.99 |
| 营业成本 | 154,823,720.6 | 813,655,581.55 | 602,894,902.19 | 376,386,318.97 |
| 利息支出 | 0 | - | - | 0 |
| 手续费及佣金支出 | 0 | - | - | 0 |
| 退保金 | 0 | - | - | 0 |
| 赔付支出净额 | 0 | - | - | 0 |
| 提取保险合同准备金净额 | 0 | - | - | 0 |
| 保单红利支出 | 0 | - | - | 0 |
| 分保费用 | 0 | - | - | 0 |
| 税金及附加 | 2,826,212.5 | 11,168,355.23 | 8,093,347.19 | 5,252,675.21 |
| 销售费用 | 26,578,861.77 | 139,462,220.36 | 101,207,686.47 | 70,184,233.49 |
| 管理费用 | 21,180,671.07 | 65,769,064.86 | 42,629,652.2 | 26,943,052.09 |
| 研发费用 | 824,511.42 | 6,164,479.84 | 4,952,013.58 | 2,197,337.4 |
| 财务费用 | 4,143,105.88 | 17,961,997.44 | 13,005,052.01 | 8,680,620.83 |
| 其中:利息费用 | 4,604,729.4 | 21,844,269.22 | 16,086,350.4 | 10,874,156.48 |
| 其中:利息收入 | 720,867.12 | 4,457,137.59 | 3,479,193.97 | 2,465,740.06 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 0 | 4,791,700 | 2,812,900 | 2,812,900 |
| 加:投资收益 | -808,868.35 | 1,458,303.05 | 6,143,469.49 | 8,540,958.53 |
| 汇兑收益 | 0 | - | - | 0 |
| 资产处置收益 | 1,120,636.26 | -1,966,709.33 | -20,148.4 | 12,472.11 |
| 资产减值损失(新) | -4,212,557.9 | -11,337,879.63 | -10,334,352.42 | -10,334,352.42 |
| 信用减值损失(新) | 0 | 4,143,012.26 | 2,738,606.98 | 2,738,606.98 |
| 其他收益 | 1,159,581.9 | 3,035,349.58 | 3,869,782.15 | 1,465,032.33 |
| 四、营业利润 | -2,499,601.49 | 7,813,512.96 | 3,735,902.32 | 3,581,668.59 |
| 加:营业外收入 | 12,680 | 2,823,541.6 | 2,381,649.68 | 568,707.92 |
| 减:营业外支出 | 35,770.07 | 1,524,908.76 | 1,170,613.37 | 794,667.76 |
| 五、利润总额 | -2,522,691.56 | 9,112,145.8 | 4,946,938.63 | 3,355,708.75 |
| 减:所得税费用 | 598,740.1 | 3,138,230.24 | 3,010,256.28 | 2,632,020.32 |
| 六、净利润 | -3,121,431.66 | 5,973,915.56 | 1,936,682.35 | 723,688.43 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -3,121,431.66 | 6,520,725.62 | 1,936,682.35 | 723,688.43 |
| 终止经营净利润 | 0 | -546,810.06 | 0 | 0 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -3,366,972.78 | 6,727,107.03 | 3,084,346.69 | 1,767,953.61 |
| 少数股东损益 | 245,541.12 | -753,191.47 | -1,147,664.34 | -1,044,265.18 |
| 扣除非经常损益后的净利润 | -5,147,111.04 | -13,314,235.14 | -16,318,622.64 | -15,056,060.93 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0 | 0.01 | 0 | 0 |
| (二)稀释每股收益 | 0 | 0.01 | 0 | 0 |
| 八、其他综合收益 | 0 | - | - | 0 |
| 归属于母公司股东的其他综合收益 | 0 | - | - | 0 |
| 九、综合收益总额 | -3,121,431.66 | 5,973,915.56 | 1,936,682.35 | 723,688.43 |
| 归属于母公司股东的综合收益总额 | -3,366,972.78 | 6,727,107.03 | 3,084,346.69 | 1,767,953.61 |
| 归属于少数股东的综合收益总额 | 245,541.12 | -753,191.47 | -1,147,664.34 | -1,044,265.18 |
| 公告日期 | 2026-04-22 | 2026-03-31 | 2025-10-25 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |